Log in
Enquire now

List of Reven Pharmaceuticals patents

List of Reven Pharmaceuticals patents
List of Symbotic patents
List of Asterias Biotherapeutics patents
List of PACE patents
List of companies in Panony's investment portfolio
List of companies in Creative Destruction Lab's investment portfolio
Patents where
Current Assignee
Name
is
Reven PharmaceuticalsReven Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9572810 Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

Patent 9572810 was granted and assigned to Reven Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9572810
February 21, 2017
‌
US Patent 9867849 Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

Patent 9867849 was granted and assigned to Reven Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9867849
January 16, 2018
‌
US Patent 9775798 Compositions and methods for the prevention and treatment of cardiovascular diseases

Patent 9775798 was granted and assigned to Reven Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9775798
October 3, 2017
‌
US Patent 9089602 Compositions and methods for the prevention and treatment of cardiovascular diseases

Patent 9089602 was granted and assigned to Reven Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9089602
July 28, 2015
‌
US Patent 9089511 Compositions and methods for the prevention and treatment of cardiovascular diseases

Patent 9089511 was granted and assigned to Reven Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9089511
July 28, 2015
‌
US Patent 10849848 Compositions and methods for the prevention and treatment of cardiovascular diseases

Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10849848
December 1, 2020
‌
US Patent 9101537 Compositions and methods for the prevention and treatment of cardiovascular diseases

Patent 9101537 was granted and assigned to Reven Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.

Reven Pharmaceuticals
Reven Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9101537
August 11, 2015
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us